It was announced this week that a new blood based test for the detection of variant CJD has been developed by a group in London, UK. The assay had a sensitivity of 71.4% and a specificity of 100%. The only positive samples detected were from patients with variant CJD. This assay is not currently available […]
A paper describing the EUHASS program has been published. The manuscript can be downloaded from here
5 JAN 2011
24 SEPT 2010 – OCTAGAM IMMUNOGLOBULIN SUSPENDED
Amorfix Life Sciences Ltd has announced that it has decided to suspend all development of their vCJD diagnostic test. Amorfix was considered to have been the leader in the race to develop a blood test to diagnose vCJD. Following the failure of their test to identify the plasma from a UK vCJD patient as positive the company has decided to abandon work on this test.
31 MAY 2010